97 studies found for:    Open Studies | "Pulmonary Fibrosis"
Show Display Options
Rank Status Study
21 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
22 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
23 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
24 Unknown  Explanted Lung Tissues With Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention:
25 Unknown  Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Iloprost inhalation
26 Recruiting Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab
Condition: Pulmonary Fibrosis
Interventions: Drug: Bevacizumab;   Drug: Dexamethasone
27 Recruiting A Study on Radiation-induced Pulmonary Fibrosis Treated With Clinical Grade Umbilical Cord Mesenchymal Stem Cells
Condition: Post-radiotherapy Pulmonary Fibrosis
Intervention: Biological: clinical grade umbilical cord mesenchymal stem cells
28 Recruiting Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention:
29 Recruiting Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Pulmonary Fibrosis
Intervention:
30 Recruiting Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
31 Unknown  Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention: Drug: pomalidomide (CC-4047
32 Recruiting Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
33 Recruiting Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
34 Not yet recruiting Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Dyspnoea;   Anxiety;   Depression
Intervention:
35 Recruiting Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: BMS-986020;   Drug: Placebo matching with BMS-986020
36 Recruiting A Study of Lebrikizumab in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: lebrikizumab;   Drug: placebo
37 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
38 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
39 Available Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Pirfenidone
40 Recruiting STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Interventions: Drug: BG00011;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years